アフターアワーズ： 1.83 -0.01 -0.54%

Compass Therapeutics Inc (CMPX)

Compass Therapeutics Inc (CMPX) 最新ニュース

Compass Therapeutics Inc (CMPX)

Compass Therapeutics Inc (CMPX) 最新ニュース

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat

Rhumbline Advisers Takes Position in Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) - Defense World

Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World

Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World

PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World

Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World

Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR

Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News

Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World

Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World

Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World

A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News

Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN

Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World

Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada

Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat

Executive team - Compass Pathways

National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World

Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex

Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World

Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World

Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World

Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World

Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World

Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World

Bank of New York Mellon Corp Acquires 22,310 Shares of ICU Medical, Inc. (NASDAQ:ICUI) - Defense World

Panagora Asset Management Inc. Purchases New Stake in Wingstop Inc. (NASDAQ:WING) - Defense World

Panagora Asset Management Inc. Sells 2,087 Shares of MSA Safety Incorporated (NYSE:MSA) - Defense World

Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's Why - Yahoo Finance UK

Compass Therapeutics Inc (CMPX) presents a great opportunity, but the stock is slightly undervalued - US Post News

CMPX: A Tale of Ups & Downs – -16.84% loss in 6 Months, 58.62% in 30 Days - The InvestChronicle

Compass Therapeutics to Participate in Upcoming Investor Events - GlobeNewswire

Compass Therapeutics to Participate in Upcoming Investor Events - Yahoo Finance

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - Defense World

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat

CMPX’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Eliem Therapeutics appoints new COO Brett Kaplan - Investing.com

Eliem Therapeutics Announces Additions to its Leadership Team - ForexTV.com

Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire

Eliem Therapeutics Announces Additions to its Leadership Team - GlobeNewswire Inc.

Financial Comparison: Voyager Therapeutics (NASDAQ:VYGR) versus Compass Therapeutics (NASDAQ:CMPX) - Defense World

Institutional investors own a significant stake of 50% in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Yahoo Finance

Compass Therapeutics, Inc. (NASDAQ:CMPX) Sees Large Decrease in Short Interest - MarketBeat

Q3 2024 EPS Estimates for Abeona Therapeutics Inc Cut by Analyst (NASDAQ:ABEO) - Defense World

Compass Therapeutics, Inc. to Post Q3 2024 Earnings of ($0.11) Per Share, Wedbush Forecasts (NASDAQ:CMPX) - Defense World

Wedbush Weighs in on Compass Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:CMPX) - MarketBeat

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Vanguard Group Inc. - Defense World

FY2024 EPS Estimates for Centric Health Corp. (TSE:CRX) Decreased by Cormark - Defense World

Brokers Offer Predictions for Compass Therapeutics, Inc.’s FY2024 Earnings (NASDAQ:CMPX) - Defense World

Roth Capital Equities Analysts Reduce Earnings Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) - Defense World

Compass Therapeutics, Inc. (NASDAQ:CMPX) to Post Q3 2024 Earnings of ($0.14) Per Share, Leerink Partnrs Forecasts - Defense World

FY2028 EPS Estimates for Compass Therapeutics, Inc. Boosted by Analyst (NASDAQ:CMPX) - MarketBeat

Equities Analysts Set Expectations for Atossa Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:ATOS) - Defense World

California State Teachers Retirement System Reduces Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Q3 2024 EPS Estimates for Esperion Therapeutics, Inc. (NASDAQ:ESPR) Reduced by HC Wainwright - Defense World

You might want to take a look at Compass Therapeutics Inc (CMPX) now - SETE News

Compass Therapeutics (NASDAQ:CMPX) Announces Quarterly Earnings Results - Defense World

Market Watch Highlights: Compass Therapeutics Inc (CMPX) Ends on an Upturn Note at 1.20 - The Dwinnex

Compass Therapeutics (NASDAQ:CMPX) Issues Earnings Results - MarketBeat

Compass Therapeutics (NASDAQ:CMPX) Receives Buy Rating from HC Wainwright - Defense World

Compass Therapeutics (NASDAQ:CMPX) Given "Buy" Rating at HC Wainwright - MarketBeat

CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024 - InvestorPlace

Examining Compass Therapeutics Inc (CMPX) more closely is necessary - US Post News

Regulus Therapeutics Inc. Forecasted to Earn Q2 2025 Earnings of ($0.20) Per Share (NASDAQ:RGLS) - Defense World

Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update - GlobeNewswire

Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update - Yahoo Finance

CMPXに似た銘柄